EP Patent

EP1589959A2 — Methods of treating lower urinary tract disorders using sodium channel modulators

Assigned to Dynogen Pharmaceuticals Inc · Expires 2005-11-02 · 21y expired

What this patent protects

The invention relates to methods of using sodium channel modulators, particularly TTX-R sodium channel modulators and/or activity dependent sodium channel modulators to treat painful and non-painful lower urinary tract disorders, particularly painful and non-painful overactive bl…

USPTO Abstract

The invention relates to methods of using sodium channel modulators, particularly TTX-R sodium channel modulators and/or activity dependent sodium channel modulators to treat painful and non-painful lower urinary tract disorders, particularly painful and non-painful overactive bladder with and/or without loss of urine.

Drugs covered by this patent

Patent Metadata

Patent number
EP1589959A2
Jurisdiction
EP
Classification
—
Expires
2005-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Dynogen Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.